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SUMMARY
1. Atrial natriuretic peptide (ANP) levels were
measured in cardiac tissues and in plasma from adult rats
exposed to chronic alveolar hypoxia for periods of 2 h,
24 hand 7 days. Levels were also measured in rats that
were maintained in hypoxia for 7 days and then returned
to air for 24 h.
2. Plasma ANP was not altered at 2 h but was signifi-
cantly increased at both 24 h and at 7 days. Plasma ANP
in animals exposed to hypoxia for 7 days was normal 24 h
after returning to air breathing, despite the persistence of
indices of pulmonary hypertension.
3. No significant right atrial hypertrophy was observed
under these conditions of chronic hypoxia. A reduction in
right atrial ANP content was found at 24 h and was
accompanied by a decrease in the number of electron-
dense granules per right atrial muscle cell. After exposure
to hypoxia for 7 days, right atrial ANP and granule
number was not different from control, and no alteration
was found in right atrial ANP level after removal from the
hypoxic environment.
4. No significant right ventricular hypertrophy was
produced by exposure to hypoxia for 2 or 24 h. In the
former group ventricular ANP had decreased signifi-
cantly compared with control. Right ventricular hypertro-
phy was found in both the hypoxic groups after exposure
for 7 days, when selective increases in right ventricular
ANP content were found.
5. These findings are consistent with the hypothesis
that ANP release occurs on exposure to chronic hypoxia
and is independent of the associated cardiac hypertrophy
and pulmonary vascular remodelling. The findings m~y
have relevance to the natriuresis and reported changes III
the renin-angiotensin-aldosterone axis under hypoxic
conditions.
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INTRODUCTION
Mammalian atrial muscle cells possess numerous
electron-dense granules containing the 28 amino acid
atrial natriuretic peptide (ANP) stored as a 126 amino
acid prohormone [1]. Release occurs in response to atrial
distension [2] and can be modified by volume loading [3]
and by alteration of venous return [4]or, more directly, by
induced disorders of cardiac rhythm [5]. Smaller quanti-
ties of ANP immunoreactivity are found in ventricular
tissue, but the role of this and other extra-atrial sites may
have in secretion are not understood. In addition to
described natriuretic and vasorelaxant effects, ANP has
important regulatory actions on the renin-angioten-
sin-aldosterone system that are seen at physiological con-
centrations of the peptide [6]. Thus ANP inhibits the
stimulation by angiotensin II, adrenocorticotrophic hor-
mone and potassium of aldosterone secretion by rat
adrenal glomerulosa cells [7].An inhibitory effect of ANP
in vivo has also been documented on the action of
endogenously released angiotensin II-stimulated aldo-
sterone secretion [8].
Natriuresis and diuresis are conspicuous features of
exposure to chronic hypoxia in man, and individual differ-
ences have been considered to be an important factor in
the development of altitude sickness [9]. Milledge et al.
[10] found increased levels of plasma renin activity in
humans at altitude and have shown reduced aldosterone
responses for a given increment in plasma renin activity.
These findings have been subsequently confirmed by
other investigators [11]. The suggested mechanism was a
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decreased level of plasma angiotensin-converting enzyme
activity, but this possibility has not been supported by
further experiments [12].
Thus, a body of evidence now exists to suggest a
change in salt and water homoeostasis and an altered
inter-relationship between the components of the
renin-angiotensin-aldosterone axis in hypoxia. We there-
fore reasoned that if right heart pressures were raised as a
result of hypoxic pulmonary artery vasoconstriction, then
ANP release might occur and explain the observed
changes in aldosterone secretion. We have therefore
investigated this possibility by simultaneous measurement
of ANP immunoreactivity in plasma and cardiac tissue
(prepared from both pre-hypertrophied and hyper-
trophied tissue) during 7 days exposure to chronic
hypoxia and recovery. A further aim was to study the




Male Wistar rats in the weight range 250-400 g were
used for these experiments. They were maintained in a
flexible film hypoxic chamber [fractional inspired oxygen
(Fio2)= 10%] with carbon dioxide and excess humidity
removed by means of filters [13]. The fractional oxygen
concentration was continuously monitored by a polaro-
graphic oxygen analyser. Gas was sampled periodically
for analysis by mass spectrometer and showed Fio2 to be
within 0.5% of the prescribed level and FIC02 to be less
than 0.2% at all times. Pellet diet and water were given to
all groups ad libitum. Normoxic control animals were
kept in the same room and exposed to the same
light-dark cycle.
Experimental design
Experiment 1. Animals were removed after exposure
to hypoxia for 2 or 24 h and were compared with controls
in normoxia (10 animals in the three groups).
Experiment 2. Animals were maintained in the hypoxic
environment for 7 days and compared with their nor-
moxie control group. In this study an additional group
was removed after 7 days in the hypoxic chamber and
allowed to recover in normoxic conditions for a further
24 h (10 animals in the three groups).
Measurements and collection of samples
Tissue and plasma were collected from the six groups
at the same time of day to obviate any effect of diurnal
variation [14]. Particular care was taken to avoid stress
during the handling of the animals. A short time ( < 10
min) after removal from their respective environments
blood was obtained by decapitation. This method was
used for collection of blood because anaesthetic agents
reportedly have a large effect on plasma levels of ANP
[15]. Plasma was removed, samples frozen rapidly and
stored at - 20°C until assay. The heart and lungs were
removed en bloc, and the heart was separated. The right
ventricle was opened at the apex and together with the
right atrium was dissected free. The right atrium was then
separated. The left ventricle and septum were removed
and left atrium and aortic root were removed. The right
ventricle, right atrium and left ventricle were lightly
blotted and then weighed using a chemical balance. Right
ventricular and right atrial hypertrophy was expressed as
right ventricular weight/left ventricular weight (RV/LVW)
and right atrial weight/left ventricular weight (RA/LVW),
respectively. This method has been used because left ven-
tricular weight relative to log (body weight) does not alter
under conditions of hypoxia, whereas right ventricular
weight relative to both log (body weight) and left ventricu-
lar weight is increased, reflecting selective hypertrophy of
this chamber [16]. As in previous experiments the septum
was included with the left ventricle, since functionally it
forms part of it [17].
After the right atrium and right ventricle were divided,
the parts to be used for radioimmunoassay of ANP con-
tent were weighed and then extracted in boiling 0.5 mol/I
acetic acid for 10 min. A ratio of 1:10 wet weight of
tissue/volume of 0.5 mol/l acetic acid was employed, thus
a volume of 0.5-1.0 ml was used depending on the tissue
weight. This is a well-validated method of extraction that
has been used for several different peptides [18] and has
been used previously for ANP [19]. Tissue extracted was
stored at - 20°C until later assay.
Portions of fresh right atrial tissue were immediately
cut into 1 mm cubes, fixed in 3% (v/v) glutaraldehyde
(2 h) and post fixed in 1% (w/v) osmium tetroxide (1 h).
Blocks were processed by standard procedures and
embedded in epoxy resin. Ultrathin sections were cut with
glass knives, stained by uranyl acetate/lead citrate (0.12%,
w/v), and examined in an AEI 801 electron microscope.
Radioimmunoassay of ANP
Plasma ANP immunoreactivity was measured by direct
assay of plasma [20]. Serial plasma dilution curves were
found to be parallel with the synthetic a-ANP standard.
The plasma sample volume was 100 ,Ill, assayed in dupli-
cate as previously. The assay detection limit in rat plasma
is 5 frnol/rnl. Tissue ANP reactivity was measured by the
addition of 10 ,Ill of the acid extract, directly (for ven-
tricles) or after 1:1000 or 1:10 000 dilution (for the atria)
to the assay tubes. Samples from each experiment were
assayed at the same time as their normoxic controls, to
overcome any difficulties in interpretation as a result of
known interassay variability. Moreover, since measure-
ment of tissue ANP requires an initial extraction process,
we considered it especially important not to use historical
controls. Tissue ANP levels were expressed per g wet
weight.
Atrial granule morphometry
Semi-quantitative estimation of the atrial muscle
electron-dense granules was undertaken. Comparison was
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made between the 24 h hypoxic and normoxic groups
(experiment 1), and between 7 day hypoxic (experiment
2) and normoxic animals. The number of granules was
counted in three cells per animal, where abundant cyto-
plasm surrounded each pole of the nucleus. Assessment
was made by the same observer from electron micro-
graphs at the same magnification (x 8000). Four
animals were assessed in both the hypoxic groups
together with four normoxic control animals.
Data analysis
Values for cardiac hypertrophy, tissue and plasma ANP
were compared with an analysis of variance. Comparison
between the granule count in the groups was made with




Individual results for cardiac hypertrophy are given in
Figs. l(a) (experiment 1) and l(b) (experiment 2). No
significant right atrial or right ventricular hypertrophy was
apparent up to 24 h: RA/LVW (mean ±SEM) was
0.072 ± 0.004 in the control group, which was not signifi-
cantly different from the values of 0.068 ± 0.005 and
0.077 ± 0.006 at 2 and 24 h hypoxia, respectively, as
shown in Fig. l(a). The corresponding values for RV/
LVW were 0.214±0.009 in the control group, and
0.237 ± 0.008 and 0.239 ± 0.009 for exposure to hypoxia
for 2 and 24 h, respectively (both non-significant).
No significant change in RA/LVW was seen in either
group after 7 days hypoxia: RA/LVW was 0·075 ± 0·006
in control animals, 0·088 ± 0·008 in 7 day hypoxia and
0·096 ± 0·007 in hypoxia and recovery as shown in Fig.
1(b). After 7 days significant right ventricular hyper-
trophy was seen (RV/LVW hypoxic 0.320±0.012;
normoxic 0.224±0.012, P<O.OOl) that was also present
in the group returned to air breathing for a further 24 h
(RV/LVW 0.316 ± 0.015, P< 0.001, n = 10).
PlasmaANP
Plasma ANP was increased after 24 h hypoxia (24 ± 1
pmol/l) compared with control (19 ± 1 pmol/l, P< 0.05,
n = 10), but not after 2 h hypoxia (21 ± 1 pmol/I) as
shown in Fig. 2. After 7 days hypoxia a 60% increase in
plasma ANP was found (hypoxic 43 ± 3 pmol/l, control
27 ±2 pmol/l, P< 0.01). Plasma ANP was normal in the
hypoxic group returned to air breathing for 24 h (30 ± 2
pmol/I) and was not significantly different from control
animals (Fig. 3).
Ventricular ANP
In the pre-hypertrophied ventricle a significant deple-
tion of ventricular ANP was evident after 2 h hypoxic
exposure (16 ± 3 pmol/g wet tissue compared with
62± 15 pmol/g wet tissue in controls, P<O.Ol, n= 10).
Right ventricular ANP levels were 70 ± 17 pmol/g after
24 h, not different from controls (Fig. 2). In experiment 2,
the levels of ANP in the hypertrophied right ventricular
tissue were 30 ± 5 and 27 ± 4 pmol/g, after 7 days and 7
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Fig. 1. Relative right ventricular (RV/LVW) and right atrial (RA/LVW) weight in experiment 1
(a) and experiment 2 (b). Statistical significance: "P«. 0.001.
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Atrial electron-dense granules
Examination was made at 24 h and after 7 days. At
24 h t~ere was a decrease in the number of granules per
cell, with 110 ± 13 granules per cell in control group com-
pared with 50±9 in the hypoxic group (P<O.Ol) (Figs. 4
and 5). After 7 days the number of granules per cell was
99 ± 13 per cell, not significantly different from control.
DISCUSSION
~he use of this model enabled us to examine changes in
tissue ANP and granule morphometry, in tandem with
plasma levels, during various periods of hypoxic exposure
and recovery.
.The increases. i? RV/LVW indicate that the hypoxic
stimulus was sufficient to produce right ventricular hyper-
trophy after exposure of 1 week, but not after 24 h. These
~ndings are conc?rdant with information about the early
time course at this level of hypoxia in rats, where detect-
able pulmonary hypertension, pulmonary vascular re-
modelling, significant increases in packed cell volume and
right ventricular hypertrophy are seen after as little as 4
days [21]. Limited information is available about whether
the.re are. also changes in the relative weight of the right
~tnum With pro~onged hypoxia, but we did not find signi-
flc~nt changes III RA/LVW, the chosen index of right
atnal hypertrophy, suggesting that this is not a feature of
early exposure.
The results show clearly that plasma ANP is increased
during the initial 7 days exposure to chronic hypoxia,
from as early as 24 h. The concomitant reduction in atrial
levels suggests that the initial increase in plasma ANP was
derived from an atrial source. This is further supported by
the reduction in electron-dense granules in right atrial
tissue at 24 h. This contrasts with the findings at 7 days
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Fig. 4. Number of electron-dense granules/muscle cell in
right atrial tissue from controls, 2 hand 24 h hypoxic
groups. The number of granules was counted in three
cells per animal, where abundant cytoplasm surrounded
each pole of the nucleus (see the Methods section). n = 4
animals in each group. Statistical significance: *P< 0.01.
no~al rig~t atrial ANP levels and atrial granule number,
~hl~h we interpret as showing increased synthesis. The
f~?lllg that after 24 h removal from the hypoxic con-
ditions plasma ANP had returned to normal, without
detectable accumulation of ANP in the right atrium, also
shows that ANP synthesis adjusts rapidly after removal
from a provocative stimulus.
In the study we tried to examine whether ANP release
was the result of the hypoxia itself, or of associated
cardiac and pulmonary vascular remodelling. Experiment
2 was designed to dissociate these two possible stimuli
through the inclusion of a group returned to air breathing
after hypoxic exposure. Although pulmonary vascular
remodelling takes as little as 4 days to develop in these
conditions, it persists for a surprisingly long period after
removal; this disparity between rapid development and
slow devolution has been well described previously [22].
Although not measured directly, previous work has indi-
cated that the group allowed to recover would have had
raised pulmonary artery pressures as a result of pul-
monary vascular remodelling, since RV/LVW is known
to be closely correlated with pulmonary artery pressure in
this model [23]. Thus, if raised pulmonary artery pressure
were directly or indirectly the main signal for ANP
release, then increased levels would be predicted in the
group allowed to recover, but this was not found. It is not
possible to accurately measure atrial pressure in con-
scious animals within the chamber, but removal from the
hypoxic environment may have been associated with a
reduction in right atrial pressure and may have been the
mechanism involved (through relief of hypoxic pulmonary
artery vasoconstriction and right ventricular pressure
overload). The observation that plasma ANP was normal
after 24 h air breathing could also be explained by a
capability of the system to reset to higher pressure levels,
and thus sensing pressure change rather than absolute
levels.
The finding of a 74% reduction in the ventricular ANP
content after 2 h hypoxia shows that the ventricle is
capable of responding quickly to pressure overload. That
this large decrease in right ventricular immunoreactivity
after 2 h was not accompanied by an increased plasma
level suggests that ANP derived from the non-hyper-
trophied ventricle does not contribute to any appreciable
extent to plasma levels, a finding that may reflect the
1000-fold smaller concentration of ANP immunoreac-
tivity in the ventricles compared with the atria. However,
depletion of ventricular ANP immunoreactivity has been
seen in patients with heart failure, raising the possibility
that this and perhaps other extra-atrial sources may have
a role in certain pathophysiological conditions [24]. The
considerable increase in right ventricular ANP immuno-
reactivity in hypertrophy found after 7 days hypoxia is
unexplained on the basis of present knowledge; further-
more, because ANP levels were expressed per g wet
weight of tissue, the selective increase seen in the hyper-
trophied right ventricle implies an even greater increase in
total ANP immunoreactivity at this site. Cardiac tissue
ANP will be determined by the balance between synthesis
and release, and the change in ventricular content seen in
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Fig. 5. Electron micrographs (original magnification x 8000) of representative right atrial
muscle cells in lnormoxic tissue (a) and 24 h hypoxic tissue (b).
experiment 2 raises the possibility that this balance has in
some way been reset under conditions of hypertrophy.
These studies, however, do not allow one to comment
directly upon the synthesis of ANP. It will be of particular
interest to employ quantitative hybridization methods in
situ to obtain, more directly, information about ANP
synthesis under conditions of hypoxia and selective
ventricular hypertrophy.
These results showing a substantial increase in plasma
ANP in hypoxia accord with a previous paper describing
increases in rats after 21 days exposure to chronic
hypoxia [25]. Our finding that plasma ANP is increased
during the first 7 days of exposure to hypoxia, is in keep-
ing with a physiological role for the peptide in the natri-
uresis and changes in the renin-angiotensin-aldosterone
system, since both occur during the initial few days
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exposure [9, 10]. The physiological importance of these
findings was outside the scope of the present enquiry but
will be an important area for further study, as will their
applicability to man. Changes in ANP may only partly
explain the observed natriuresis in hypoxia, since studies
in denervated cats, where ventilation and renal perfusion
were closely controlled, have pointed to the importance
of a humoral agent released after carotid body stimulation
[26]. The relative importance of ANP, the renin-angioten-
sin-aldosterone cascade system and the carotid body
requires further study, but there is now evidence to
suggest that these operate together to effect the changes in
water and sodium balance in hypoxic conditions.
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